What is the primary objective of GMP?

GMP establishes minimum standards for manufacturing controls to ensure products are consistently produced and controlled to meet predefined quality criteria. It prevents contamination, mix-ups, mislabeling, and process variability through preventive systems including validated processes, independent quality oversight, personnel training, facility controls, and documentation, as codified in FDA 21 CFR Parts 210/211 and EU EudraLex Volume 4.

Who is legally or professionally required to comply with GMP?

GMP compliance is legally required for manufacturers of pharmaceuticals, biologics, APIs, and related products under FDA 21 CFR Parts 210/211, EU EudraLex Volume 4, and WHO GMP. This includes drug product facilities, API producers per ICH Q7, contract manufacturers, and suppliers; enforcement applies via inspections, with Qualified Persons (EU Annex 16) holding batch release accountability.

Does GMP require an external audit or third-party certification?

GMP does not mandate third-party certification but requires regular regulatory inspections by authorities like FDA and EMA. Organizations must conduct internal audits/self-inspections and supplier audits; PIC/S and MRAs enable mutual recognition, but compliance is verified through unannounced official audits, not voluntary certification schemes.

How often should an assessment for GMP be performed?

GMP assessments, including internal audits and self-inspections, must be conducted at planned intervals per a risk-based schedule. FDA and EU GMP require annual product quality reviews (§211.180(e)), ongoing monitoring via CAPA and management review (ICH Q10), with requalification triggered by changes, maintenance, or trends; regulatory inspections occur unannounced based on risk.

What are the consequences of non-compliance with GMP?

Non-compliance with GMP triggers regulatory actions including Form 483 observations, Warning Letters, import alerts, product seizures, consent decrees with financial penalties, recalls, and manufacturing halts. Historical cases like Elixir Sulfanilamide demonstrate patient harm; executives face consent decrees, criminal liability for adulteration, and multimillion-dollar remediation costs.

An GMP be mapped to other international frameworks?

Yes, GMP maps closely to ICH Q7 (API), Q9 (QRM), Q10 (PQS), PIC/S, and WHO GMP for global harmonization. FDA 21 CFR 211 aligns with EU EudraLex Volume 4 principles like quality systems and validation; MRAs reduce duplication, though EU annexes (e.g., Annex 1 sterile products) add specificity.

What is the first step to begin implementing GMP?

The first step is conducting a comprehensive gap analysis against applicable regulations like 21 CFR 211 or EU GMP to identify deficiencies. This informs a Validation Master Plan (VMP), prioritizes risks via QRM (ICH Q9), and establishes executive governance for remediation roadmap, resource allocation, and PQS design.

What is the primary objective of ISO 27701?

ISO 27701 defines requirements and guidance for establishing, implementing, maintaining, and continually improving a Privacy Information Management System (PIMS). It governs the PII lifecycle—collection, processing, retention, and disposal—for PII controllers and processors, emphasizing demonstrable accountability, privacy risk management, and alignment with privacy laws via Clauses 4–10 and Annexes A/B.

Who is legally or professionally required to comply with ISO 27701?

No organization is legally required to comply with ISO 27701, as it is a voluntary international standard. It applies professionally to any entity acting as PII controllers or processors handling personally identifiable information, across sectors like finance, healthcare, SaaS, and retail, from SMBs to global enterprises needing auditable privacy governance.

Does ISO 27701 require an external audit or third-party certification?

ISO 27701 does not require external audit or third-party certification, but certification is available via accredited bodies. The 2025 edition requires integration with ISO 27001 audits as an extension rather than a stand-alone PIMS certification, involving Stage 1 (documentation) and Stage 2 (implementation verification), valid for three years with annual surveillance audits.

How often should an assessment for ISO 27701 be performed?

ISO 27701 requires periodic internal audits and management reviews as part of the PDCA cycle, with frequency determined by risk and performance. Certification involves annual surveillance audits and full recertification every three years; organizations conduct ongoing assessments via KPIs, internal audits, and continual improvement under Clause 9.

What are the consequences of non-compliance with ISO 27701?

Non-compliance with ISO 27701 itself carries no direct penalties, as it is not legally binding. However, failure to implement effective PIMS exposes organizations to privacy law fines (e.g., GDPR up to 4% global turnover), reputational damage, contractual losses, data breaches, and exclusion from procurement requiring certified privacy assurances.

Can ISO 27701 be mapped to other international frameworks?

Yes, ISO 27701 provides explicit mappings to frameworks like GDPR (Annex D), ISO/IEC 27001/27002 (Annex F), ISO/IEC 29100 (Annex C), and ISO/IEC 27018/29151 (Annex E). These enable integrated compliance, reusing ISMS controls while adding privacy-specific requirements for controllers/processors.

What is the first step to begin implementing ISO 27701?

The first step is Phase 1: Discover & Scope, securing executive sponsorship and conducting context analysis. Define PIMS scope, roles (controller/processor), PII inventory/data flows, gap analysis against Clauses 4–10 and Annexes, and initial privacy risk assessment to produce a scope statement and roadmap.

Standards Comparison

GMP vs ISO 27701

GMP

Mandatory

1963

Regulatory framework for pharmaceutical manufacturing quality control

ISO 27701

Voluntary

2019

International standard for privacy information management systems

Quick Verdict

GMP ensures manufacturing quality in pharma and food via preventive controls and validation, while ISO 27701 certifies privacy governance for PII handling across industries. Companies adopt GMP for regulatory compliance and ISO 27701 for auditable privacy accountability.

Manufacturing Quality

GMP

Good Manufacturing Practices (GMP)

Cost

€€€

Complexity

Medium

Implementation Time

18-24 months

Key Features

Independent quality unit batch release authority
Validated processes and equipment qualification (IQ/OQ/PQ)
Quality Risk Management (QRM) proportionality principles
ALCOA+ data integrity and documentation controls
Continual improvement via CAPA and audits

Privacy Management

ISO 27701

ISO/IEC 27701:2025 Privacy Information Management

Cost

€€€

Complexity

High

Implementation Time

6-12 months

Key Features

PIMS framework extending ISO 27001 for privacy
Separate controls for PII controllers and processors
Risk-based assessments and DPIAs required
GDPR and regulatory mappings in annexes
Auditable evidence for data subject rights

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

GMP Details

What It Is

Good Manufacturing Practices (GMP), including FDA 21 CFR Parts 210/211 and EU EudraLex Volume 4, is a regulatory framework establishing minimum standards for manufacturing controls. Its primary purpose is ensuring products like pharmaceuticals are consistently produced to quality specifications, preventing contamination, mix-ups, and variability through preventive, risk-based approaches like Quality Risk Management (QRM).

Key Components

Core pillars: 5 Ps (People, Premises, Processes, Procedures, Products)
Pharmaceutical Quality System (PQS) with CAPA, change control, audits
Documentation (SOPs, batch records), validation (IQ/OQ/PQ), data integrity (ALCOA+)
Enforced via inspections; no central certification but compliance demonstrated through audits

Why Organizations Use It

Mandated for market access in pharma/biologics; reduces recalls, liability; enhances supply reliability and efficiency. Builds patient trust, supports global harmonization (ICH Q10, PIC/S).

Implementation Overview

Phased: gap analysis, Validation Master Plan, training, qualification, audits. Applies to manufacturers globally; high complexity for facilities/equipment upgrades, ongoing for all sizes.

ISO 27701 Details

What It Is

ISO/IEC 27701:2025 is the international standard specifying requirements and guidance for establishing, implementing, maintaining, and improving a Privacy Information Management System (PIMS). It extends ISO/IEC 27001 with privacy-specific controls for managing personally identifiable information (PII) lifecycle, using a risk-based PDCA (Plan-Do-Check-Act) approach.

Key Components

Clauses 4–10 for management system structure.
**Annex AControls for PII controllers (e.g., consent, data subject rights).
**Annex BControls for PII processors (e.g., contracts, sub-processors).
Mappings to GDPR, ISO 27002; built on ISO security standards.
Certification via accredited bodies with 3-year cycle.

Why Organizations Use It

Demonstrates accountability to regulators like GDPR.
Mitigates privacy risks, reduces fines, enhances trust.
Competitive edge in procurement, supply chains.
Harmonizes multi-jurisdictional compliance.

Implementation Overview

Phased: discover/scope, design/plan, implement/operate, validate/improve.
Involves PII inventory, DPIAs, training, audits.
Applies to all sizes/industries handling PII; integrates with ISMS.

Key Differences

Aspect	GMP	ISO 27701
Scope	Manufacturing controls for product quality/safety	Privacy management system for PII lifecycle
Industry	Pharma, biologics, food, cosmetics globally	All sectors handling PII worldwide
Nature	Regulatory requirements, legally enforceable	Voluntary certification standard
Testing	Process validation, equipment qualification, audits	Internal audits, management reviews, certification
Penalties	Recalls, warning letters, fines, shutdowns	Loss of certification, no legal penalties

Scope

GMP

Manufacturing controls for product quality/safety

ISO 27701

Privacy management system for PII lifecycle

Industry

GMP

Pharma, biologics, food, cosmetics globally

ISO 27701

All sectors handling PII worldwide

Nature

GMP

Regulatory requirements, legally enforceable

ISO 27701

Voluntary certification standard

Testing

GMP

Process validation, equipment qualification, audits

ISO 27701

Internal audits, management reviews, certification

Penalties

GMP

Recalls, warning letters, fines, shutdowns

ISO 27701

Loss of certification, no legal penalties

Frequently Asked Questions

Common questions about GMP and ISO 27701

GMP FAQ

ISO 27701 FAQ

You Might also be Interested in These Articles...

ISO 27701 2025 Update: Navigating Standalone Certification Myths, Audit Realities, and a 90-Day PIMS Launch Plan

Debunk ISO 27701 2025 standalone certification myths vs ISO 27001. Get a 90-day PIMS launch roadmap, checklists & audit prep to certify faster amid global priva

SOC 2 Audit Survival Guide: First 5 Steps to Ace Your Type 2 Audit with Infographic

Ace your SOC 2 Type 2 audit with the first 5 essential steps: evidence collection, auditor tips, red flags from SignWell's experience. Get checklists & infograp

CIS Controls v8.1 for Cloud & Kubernetes: A Practical Implementation Playbook (AWS/Azure/GCP + IaC)

Translate CIS Controls v8.1 to cloud-native: Kubernetes patterns for IAM, logging, vuln mgmt, hardening on AWS, Azure, GCP + IaC. Practical playbook for teams.

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Explore More Comparisons

See how GMP and ISO 27701 compare against other standards

Other GMP Comparisons

Other ISO 27701 Comparisons

What It Is

Key Components

Core pillars: 5 Ps (People, Premises, Processes, Procedures, Products)

Pharmaceutical Quality System (PQS) with CAPA, change control, audits

Documentation (SOPs, batch records), validation (IQ/OQ/PQ), data integrity (ALCOA+)

Enforced via inspections; no central certification but compliance demonstrated through audits

What It Is

Key Components

Clauses 4–10 for management system structure.

**Annex AControls for PII controllers (e.g., consent, data subject rights).

**Annex BControls for PII processors (e.g., contracts, sub-processors).

Mappings to GDPR, ISO 27002; built on ISO security standards.

Certification via accredited bodies with 3-year cycle.

Aspect

GMP

ISO 27701

Scope

Manufacturing controls for product quality/safety

Privacy management system for PII lifecycle

Industry

Pharma, biologics, food, cosmetics globally

All sectors handling PII worldwide

Nature

Regulatory requirements, legally enforceable

Voluntary certification standard

Testing

Process validation, equipment qualification, audits

Internal audits, management reviews, certification

Penalties

Recalls, warning letters, fines, shutdowns

Loss of certification, no legal penalties